Product Information
HEMICLOR 12.5 MG TABLET is a brand product labeled by Ingenus Pharmaceuticals LLC, priced at $0.9571 per EA under NDC 50742028590. Its NADAC has been published 50 times since Oct 22, 2025.
FDA first approved this application on Mar 17, 2025.
The High Outlier badge above means this manufacturer's average price in the chlorthalidone market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
12.5 mg/1
Manufacturer
Ingenus Pharmaceuticals LLCNDC
50742028590
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
CHLORTHALIDONEApproval Type
New Drug (NDA)
FDA Application
NDA218647FDA Approved
3/17/2025
On Market Since
3/17/2025
Pharmacological Classes
Price Statistics
The NADAC for HEMICLOR 12.5 MG TABLET has been published 50 times since Oct 22, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.9571 per EA |
|---|---|
| All-time high | $0.9574 (Apr 15, 2026) |
| All-time low | $0.9547 (Nov 19, 2025) |
| 52-week high | $0.9574 |
| 52-week low | $0.9547 |
| Median price | $0.9571 |
| Average price | $0.9568 |
| Largest weekly change | -0.2% (Nov 19, 2025) |
| Weeks tracked | 50 |
| Tracking since | Oct 22, 2025 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Ingenus Pharmaceuticals LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
chlorthalidone market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Thiazide-like Diuretic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of HEMICLOR 12.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for HEMICLOR 12.5 MG TABLET, manufactured by Ingenus Pharmaceuticals LLC, is $0.9571 per EA (NDC 50742028590), effective Sep 30, 2026.
How has the price of HEMICLOR 12.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for HEMICLOR 12.5 MG TABLET has held within roughly two percent of its current level. It has been tracked across 50 weekly CMS publications since Oct 22, 2025.
What are the highest and lowest recorded NADAC prices for HEMICLOR 12.5 MG TABLET?
Since Oct 22, 2025, the NADAC for HEMICLOR 12.5 MG TABLET has ranged from a low of $0.9547 (Nov 19, 2025) to a high of $0.9574 (Apr 15, 2026), with a median of $0.9571 per EA.
Are there cheaper alternatives to HEMICLOR 12.5 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as HEMICLOR 12.5 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures HEMICLOR 12.5 MG TABLET?
HEMICLOR 12.5 MG TABLET (NDC 50742028590) is labeled by Ingenus Pharmaceuticals LLC, and CMS classifies it as a brand product.